Cargando…

Efficacy and safety evaluation of Fanhdi(®), a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study

Detalles Bibliográficos
Autores principales: Jimenez‐Yuste, Victor, Núñez, Laura, Alvarez‐Roman, Maria Teresa, Martin‐Salces, Monica, Haya, Saturnino, Federici, Augusto B., Grifols, Carlota, Mairal, Esther, Torres, Mireia, Páez, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015987/
https://www.ncbi.nlm.nih.gov/pubmed/34735040
http://dx.doi.org/10.1111/hae.14453
_version_ 1784907314183012352
author Jimenez‐Yuste, Victor
Núñez, Laura
Alvarez‐Roman, Maria Teresa
Martin‐Salces, Monica
Haya, Saturnino
Federici, Augusto B.
Grifols, Carlota
Mairal, Esther
Torres, Mireia
Páez, Antonio
author_facet Jimenez‐Yuste, Victor
Núñez, Laura
Alvarez‐Roman, Maria Teresa
Martin‐Salces, Monica
Haya, Saturnino
Federici, Augusto B.
Grifols, Carlota
Mairal, Esther
Torres, Mireia
Páez, Antonio
author_sort Jimenez‐Yuste, Victor
collection PubMed
description
format Online
Article
Text
id pubmed-10015987
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100159872023-03-16 Efficacy and safety evaluation of Fanhdi(®), a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study Jimenez‐Yuste, Victor Núñez, Laura Alvarez‐Roman, Maria Teresa Martin‐Salces, Monica Haya, Saturnino Federici, Augusto B. Grifols, Carlota Mairal, Esther Torres, Mireia Páez, Antonio Haemophilia Letters to the Editor John Wiley and Sons Inc. 2021-11-04 2022-01 /pmc/articles/PMC10015987/ /pubmed/34735040 http://dx.doi.org/10.1111/hae.14453 Text en © 2021 The Authors. Haemophilia published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters to the Editor
Jimenez‐Yuste, Victor
Núñez, Laura
Alvarez‐Roman, Maria Teresa
Martin‐Salces, Monica
Haya, Saturnino
Federici, Augusto B.
Grifols, Carlota
Mairal, Esther
Torres, Mireia
Páez, Antonio
Efficacy and safety evaluation of Fanhdi(®), a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study
title Efficacy and safety evaluation of Fanhdi(®), a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study
title_full Efficacy and safety evaluation of Fanhdi(®), a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study
title_fullStr Efficacy and safety evaluation of Fanhdi(®), a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study
title_full_unstemmed Efficacy and safety evaluation of Fanhdi(®), a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study
title_short Efficacy and safety evaluation of Fanhdi(®), a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study
title_sort efficacy and safety evaluation of fanhdi(®), a plasma‐derived factor viii/ von willebrand factor concentrate, in von willebrand's disease patients undergoing surgery or invasive procedures: a prospective clinical study
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015987/
https://www.ncbi.nlm.nih.gov/pubmed/34735040
http://dx.doi.org/10.1111/hae.14453
work_keys_str_mv AT jimenezyustevictor efficacyandsafetyevaluationoffanhdiaplasmaderivedfactorviiivonwillebrandfactorconcentrateinvonwillebrandsdiseasepatientsundergoingsurgeryorinvasiveproceduresaprospectiveclinicalstudy
AT nunezlaura efficacyandsafetyevaluationoffanhdiaplasmaderivedfactorviiivonwillebrandfactorconcentrateinvonwillebrandsdiseasepatientsundergoingsurgeryorinvasiveproceduresaprospectiveclinicalstudy
AT alvarezromanmariateresa efficacyandsafetyevaluationoffanhdiaplasmaderivedfactorviiivonwillebrandfactorconcentrateinvonwillebrandsdiseasepatientsundergoingsurgeryorinvasiveproceduresaprospectiveclinicalstudy
AT martinsalcesmonica efficacyandsafetyevaluationoffanhdiaplasmaderivedfactorviiivonwillebrandfactorconcentrateinvonwillebrandsdiseasepatientsundergoingsurgeryorinvasiveproceduresaprospectiveclinicalstudy
AT hayasaturnino efficacyandsafetyevaluationoffanhdiaplasmaderivedfactorviiivonwillebrandfactorconcentrateinvonwillebrandsdiseasepatientsundergoingsurgeryorinvasiveproceduresaprospectiveclinicalstudy
AT federiciaugustob efficacyandsafetyevaluationoffanhdiaplasmaderivedfactorviiivonwillebrandfactorconcentrateinvonwillebrandsdiseasepatientsundergoingsurgeryorinvasiveproceduresaprospectiveclinicalstudy
AT grifolscarlota efficacyandsafetyevaluationoffanhdiaplasmaderivedfactorviiivonwillebrandfactorconcentrateinvonwillebrandsdiseasepatientsundergoingsurgeryorinvasiveproceduresaprospectiveclinicalstudy
AT mairalesther efficacyandsafetyevaluationoffanhdiaplasmaderivedfactorviiivonwillebrandfactorconcentrateinvonwillebrandsdiseasepatientsundergoingsurgeryorinvasiveproceduresaprospectiveclinicalstudy
AT torresmireia efficacyandsafetyevaluationoffanhdiaplasmaderivedfactorviiivonwillebrandfactorconcentrateinvonwillebrandsdiseasepatientsundergoingsurgeryorinvasiveproceduresaprospectiveclinicalstudy
AT paezantonio efficacyandsafetyevaluationoffanhdiaplasmaderivedfactorviiivonwillebrandfactorconcentrateinvonwillebrandsdiseasepatientsundergoingsurgeryorinvasiveproceduresaprospectiveclinicalstudy